Telesurgery, Telemonitoring, & Immersive Reality

See Video Podcast

By clicking this button, you submit your information to the webinar organizer, who will use it to communicate with you regarding this event and their other services.

Note: All registrants will receive webinar's recording and materials 2-3 days after the live webinar.

 Mar 01, 2018 Thurs | 11am - 12pm PST

Webinar Description

Is remote surgery a growing trend? Are robot-assisted surgeries becoming the norm? Whatever happened to Google Glass? Is da Vinci's market domination ending this year?

Join our next live webinar with Mark Carol, MD, neurosurgeon of 30 years and CEO of Sonacare. Discuss what is holding back surgeons from embracing telesurgery and what’s happening in the surgical technology industry that's getting us smaller, better, interconnected, self-learning devices.

Learn:

  • 2018 trends in telesurgery and augmented reality
  • Common blockers to telesurgery adoption
  • Examples of remote surgery applications
  • New players to watch in the medical device industry

 

About our Speaker

Mark Carol, M.D.  is the Chief Executive Officer & President of SonaCare Medical. Dr. Mark Carol is a neurosurgeon with over 30 years' experience in the medical device and health care services arenas in publicly traded and privately held companies. Widely viewed as the "father of IMRT" and a household name in Radiation Oncology, he has a proven track record of taking nascent disruptive technology, in multiple disparate fields, from conceptualization through commercialization.

He was the founder and CEO of NOMOS Corporation, the "first mover" in the development of 3 paradigm shifting technologies in radiation oncology, intensity modulated radiation therapy, inverse treatment planning and image-guided therapy. He was also the CMO of Xoft, Inc., and Alliance Oncology, where he developed clinical program strategies for miniature x-ray sources used to deliver therapeutic ionizing radiation (Xoft), and developed novel oncology treatments sites through JV or direct ownership (Alliance). Dr. Carol held development & consulting Medical Director positions with large NYSE and NASDAQ companies, such as Varian Medical Systems, Accuray Incorporated and Siemens Oncology.